Madera, Baby Girl Ii -.
HRN: 22-65-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/21/2023
03/28/2023
IV
25mg
Q24
Poor APGAR Score, PSNB, Premature
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes